29 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/29/2889855/0/en/RespireRx-Pharmaceuticals-Inc-Announces-a-Department-of-Defense-Award-to-Fund-a-Phase-2-Clinical-Study-to-Determine-the-Safety-and-Efficacy-of-CX1739-its-Lead-AMPAkine-to-Improve-B.html
LOOKING FOR A SUPPLIER?